Chemours Declares Quarterly Cash Dividend
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 36 minutes ago
0mins
Should l Buy CC?
Source: PRnewswire
- Quarterly Cash Dividend: Chemours' Board of Directors has declared a quarterly cash dividend of $0.0875 per share for Q2 2026, reflecting the company's stable cash flow and profitability, which helps to enhance investor confidence.
- Dividend Payment Date: This dividend will be paid on June 16, 2026, to shareholders of record as of May 17, 2026, ensuring timely returns for shareholders and further strengthening shareholder relations.
- Company Overview: Chemours is a global leader in providing industrial and specialty chemicals, serving multiple markets including coatings and refrigeration, with approximately 5,700 employees and 28 manufacturing sites, showcasing strong market coverage.
- Brand Influence: Chemours' flagship products include well-known brands such as Opteon™, Freon™, and Teflon™, and through its innovative chemical solutions, it meets customer needs across various industries, enhancing the company's competitive position.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CC
Wall Street analysts forecast CC stock price to fall
7 Analyst Rating
5 Buy
2 Hold
0 Sell
Moderate Buy
Current: 27.220
Low
13.00
Averages
16.14
High
19.00
Current: 27.220
Low
13.00
Averages
16.14
High
19.00
About CC
The Chemours Company provides industrial and specialty chemical products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. The Company’s segments include Titanium Technologies, Thermal & Specialized Solutions and Advanced Performance Materials. The Titanium Technologies segment is a provider of titanium dioxide pigment, a premium white pigment used to deliver whiteness, brightness, opacity and protection in various applications. The Thermal & Specialized Solutions segment is a provider of refrigerants, thermal management solutions, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment is a provider of high-end polymers and advanced materials. Its flagship products include brands such as Opteon, Freon, Ti-Pure, Nafion, Teflon, Viton, and Krytox. The Company serves over 2,700 customers in approximately 110 countries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Chemours Q1 Earnings Announcement Scheduled
- Earnings Release Date: Chemours is set to announce its Q1 earnings on May 5th after market close, with a consensus EPS estimate of -$0.04, reflecting a significant 130.8% year-over-year decline, indicating substantial profitability challenges ahead.
- Revenue Expectations: The anticipated revenue for Q1 stands at $1.4 billion, representing a modest 2.2% year-over-year growth, which, while limited, suggests some resilience in sales amidst broader market pressures.
- Historical Performance Review: Over the past two years, Chemours has beaten EPS estimates 50% of the time and revenue estimates 75% of the time, indicating a degree of volatility in financial performance and potential for recovery.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen no upward revisions and five downward adjustments, while revenue estimates experienced three upward revisions and two downward adjustments, reflecting a cautious market outlook on the company's future performance.
See More
Chemours Declares Quarterly Cash Dividend
- Quarterly Cash Dividend: Chemours' Board of Directors has declared a quarterly cash dividend of $0.0875 per share for Q2 2026, reflecting the company's stable cash flow and profitability, which helps to enhance investor confidence.
- Dividend Payment Date: This dividend will be paid on June 16, 2026, to shareholders of record as of May 17, 2026, ensuring timely returns for shareholders and further strengthening shareholder relations.
- Company Overview: Chemours is a global leader in providing industrial and specialty chemicals, serving multiple markets including coatings and refrigeration, with approximately 5,700 employees and 28 manufacturing sites, showcasing strong market coverage.
- Brand Influence: Chemours' flagship products include well-known brands such as Opteon™, Freon™, and Teflon™, and through its innovative chemical solutions, it meets customer needs across various industries, enhancing the company's competitive position.
See More
Chemours Declares Q2 2026 Cash Dividend of $0.0875 per Share
- Quarterly Cash Dividend: Chemours' Board of Directors has declared a cash dividend of $0.0875 per share for Q2 2026, reflecting the company's ongoing commitment to stable cash flow and shareholder returns.
- Dividend Payment Date: The dividend will be paid on June 16, 2026, to shareholders of record as of May 17, 2026, ensuring timely returns for investors and bolstering investor confidence.
- Company Overview: Chemours is a global leader in industrial and specialty chemicals, employing approximately 5,700 people across 28 manufacturing sites, serving around 2,400 customers in 110 countries, showcasing its strong market presence.
- Brands and Products: Chemours' flagship products include well-known brands such as Opteon™, Freon™, and Teflon™, highlighting the company's leadership in chemical innovation and application expertise.
See More
Alta Fundamental Advisers Cuts Chemours Stake by 175,000 Shares
- Stake Reduction Details: Alta Fundamental Advisers LLC cut its stake in Chemours (CC) by 175,000 shares during Q1, representing an estimated $3.05 million trade, indicating a potential decline in confidence in the stock.
- Position Value Change: Following the sale, Chemours' quarter-end position value decreased by $5.1 million, reflecting both trading activities and stock price fluctuations, with the current holding at 700,000 shares valued at $15.42 million.
- Portfolio Impact: Chemours now accounts for 5.8% of the fund's assets under management, making it the fifth-largest holding, suggesting that despite the reduction, Chemours remains a significant component of the investment strategy.
- Market Performance Analysis: Chemours shares have surged 136% year-to-date, significantly outperforming the S&P 500's 6.2%, yet the drastic cut in dividends last year raises caution for investors regarding future growth expectations.
See More
Chemours Exceeds Q1 2026 Financial Expectations
- Sales Growth: In Q1 2026, Chemours reported net sales of $1.381 billion, a 1% year-over-year increase driven by higher automotive refrigerant prices and currency effects, despite a 4% decline in volumes.
- Widening Net Loss: The company reported a net loss of $29 million for the first quarter, translating to a loss of $0.19 per share, significantly up from a $5 million loss in the prior year, primarily due to rising financing costs and increased administrative expenses.
- Adjusted EBITDA Performance: The adjusted EBITDA for Q1 stood at $169 million, a slight 2% increase from $166 million in the previous year, indicating that pricing and other income helped offset higher costs and lower sales volumes.
- Optimistic Future Outlook: Chemours anticipates a sequential net sales increase of 15% to 20% in Q2 2026, with adjusted EBITDA expected to range between $220 million and $250 million, reflecting a positive outlook on market demand.
See More
Chemours Q1 Non-GAAP EPS Beats Expectations, Revenue Misses Slightly
- Earnings Beat: Chemours reported a Q1 Non-GAAP EPS of $0.05, exceeding expectations by $0.09, indicating resilience in profitability despite a slight revenue miss.
- Slight Revenue Growth: Q1 revenue reached $1.38 billion, up 0.7% year-over-year, although it fell short of the $1.4 billion target, reflecting minor fluctuations in market demand.
- Optimistic Outlook: The company anticipates Q2 net sales to increase sequentially by 15% to 20%, driven by favorable seasonal trends, with Adjusted EBITDA expected to range between $220 million and $250 million.
- Long-Term Growth Expectations: Chemours expects 2026 net sales to grow by 3% to 5% over 2025, with Adjusted EBITDA projected between $800 million and $900 million, demonstrating confidence in future market conditions.
See More
Chemours Q1 Earnings Announcement Scheduled
- Earnings Release Date: Chemours is set to announce its Q1 earnings on May 5th after market close, with a consensus EPS estimate of -$0.04, reflecting a significant 130.8% year-over-year decline, indicating substantial profitability challenges ahead.
- Revenue Expectations: The anticipated revenue for Q1 stands at $1.4 billion, representing a modest 2.2% year-over-year growth, which, while limited, suggests some resilience in sales amidst broader market pressures.
- Historical Performance Review: Over the past two years, Chemours has beaten EPS estimates 50% of the time and revenue estimates 75% of the time, indicating a degree of volatility in financial performance and potential for recovery.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen no upward revisions and five downward adjustments, while revenue estimates experienced three upward revisions and two downward adjustments, reflecting a cautious market outlook on the company's future performance.
See More
Chemours Declares Quarterly Cash Dividend
- Quarterly Cash Dividend: Chemours' Board of Directors has declared a quarterly cash dividend of $0.0875 per share for Q2 2026, reflecting the company's stable cash flow and profitability, which helps to enhance investor confidence.
- Dividend Payment Date: This dividend will be paid on June 16, 2026, to shareholders of record as of May 17, 2026, ensuring timely returns for shareholders and further strengthening shareholder relations.
- Company Overview: Chemours is a global leader in providing industrial and specialty chemicals, serving multiple markets including coatings and refrigeration, with approximately 5,700 employees and 28 manufacturing sites, showcasing strong market coverage.
- Brand Influence: Chemours' flagship products include well-known brands such as Opteon™, Freon™, and Teflon™, and through its innovative chemical solutions, it meets customer needs across various industries, enhancing the company's competitive position.
See More
Chemours Declares Q2 2026 Cash Dividend of $0.0875 per Share
- Quarterly Cash Dividend: Chemours' Board of Directors has declared a cash dividend of $0.0875 per share for Q2 2026, reflecting the company's ongoing commitment to stable cash flow and shareholder returns.
- Dividend Payment Date: The dividend will be paid on June 16, 2026, to shareholders of record as of May 17, 2026, ensuring timely returns for investors and bolstering investor confidence.
- Company Overview: Chemours is a global leader in industrial and specialty chemicals, employing approximately 5,700 people across 28 manufacturing sites, serving around 2,400 customers in 110 countries, showcasing its strong market presence.
- Brands and Products: Chemours' flagship products include well-known brands such as Opteon™, Freon™, and Teflon™, highlighting the company's leadership in chemical innovation and application expertise.
See More
Alta Fundamental Advisers Cuts Chemours Stake by 175,000 Shares
- Stake Reduction Details: Alta Fundamental Advisers LLC cut its stake in Chemours (CC) by 175,000 shares during Q1, representing an estimated $3.05 million trade, indicating a potential decline in confidence in the stock.
- Position Value Change: Following the sale, Chemours' quarter-end position value decreased by $5.1 million, reflecting both trading activities and stock price fluctuations, with the current holding at 700,000 shares valued at $15.42 million.
- Portfolio Impact: Chemours now accounts for 5.8% of the fund's assets under management, making it the fifth-largest holding, suggesting that despite the reduction, Chemours remains a significant component of the investment strategy.
- Market Performance Analysis: Chemours shares have surged 136% year-to-date, significantly outperforming the S&P 500's 6.2%, yet the drastic cut in dividends last year raises caution for investors regarding future growth expectations.
See More
Chemours Exceeds Q1 2026 Financial Expectations
- Sales Growth: In Q1 2026, Chemours reported net sales of $1.381 billion, a 1% year-over-year increase driven by higher automotive refrigerant prices and currency effects, despite a 4% decline in volumes.
- Widening Net Loss: The company reported a net loss of $29 million for the first quarter, translating to a loss of $0.19 per share, significantly up from a $5 million loss in the prior year, primarily due to rising financing costs and increased administrative expenses.
- Adjusted EBITDA Performance: The adjusted EBITDA for Q1 stood at $169 million, a slight 2% increase from $166 million in the previous year, indicating that pricing and other income helped offset higher costs and lower sales volumes.
- Optimistic Future Outlook: Chemours anticipates a sequential net sales increase of 15% to 20% in Q2 2026, with adjusted EBITDA expected to range between $220 million and $250 million, reflecting a positive outlook on market demand.
See More
Chemours Q1 Non-GAAP EPS Beats Expectations, Revenue Misses Slightly
- Earnings Beat: Chemours reported a Q1 Non-GAAP EPS of $0.05, exceeding expectations by $0.09, indicating resilience in profitability despite a slight revenue miss.
- Slight Revenue Growth: Q1 revenue reached $1.38 billion, up 0.7% year-over-year, although it fell short of the $1.4 billion target, reflecting minor fluctuations in market demand.
- Optimistic Outlook: The company anticipates Q2 net sales to increase sequentially by 15% to 20%, driven by favorable seasonal trends, with Adjusted EBITDA expected to range between $220 million and $250 million.
- Long-Term Growth Expectations: Chemours expects 2026 net sales to grow by 3% to 5% over 2025, with Adjusted EBITDA projected between $800 million and $900 million, demonstrating confidence in future market conditions.
See More
